Oncaspar

According to the description, the drug "Oncaspar" is an oncological drug of a synthetic type. Medak GmbH (Germany) is a manufacturer and international company engaged in the production and sale of medicines.

The product was developed for the treatment of acute lymphoblastic leukemia in children and adults. It contains the active substance pegaspargiase and is used as maintenance therapy to help patients suffering from this form of blood cancer. This drug is contraindicated in pancreatitis, allergic reactions and pregnancy, but may have side effects. In general, it has significant